Filter by tags: Radium Germany Clear all tag filters
3 news articles found
Medical isotopes are radioactive substances used in various diagnostic and therapeutic procedures to treat various types of cancers and other conditions. They are essential for modern medicine, allowing physicians to visualise and target specific organs, tissues and cells in a patient’s body.
Over more than a decade, personalised medicine using nuclear techniques has been gaining pace, allowing doctors to tailor therapies and treatments to the specific needs and physiology of a patient, and to avoid harm to healthy organs or tissues.
According to Sven Van den Berghe, chief executive of Belgium-based isotope producer PanTera, one technique that has seen significant advances is known as theranostics – the term used to describe the combination of using one radioactive drug to diagnose and a second to deliver therapy to treat the main tumour and any metastatic tumours.
- Source: Nucnet
- Date: Friday, 14 April 2023
- Original article: nucnet.org/news/sector-aims-to-tackle-isotope-supply-problems-as-excitement-grows-over-targeted-therapies-4-4-2023
An extensive EU-funded research project has been launched to investigate the effects of chronic exposure to low doses of radon and other naturally occurring radioactive material (NORM) on humans and the environment. The EUR22 million (USD26 million), five-year RadoNorm project involves 56 partners from 22 European countries.
- Source: World Nuclear News
- Date: Tuesday, 29 September 2020
- Original article: world-nuclear-news.org/Articles/EU-research-project-focuses-on-radon-and-NORM
A new OECD/NEA report about uranium mining argues that the industry is controversial largely because of historical issues: today it is one of the most regulated and safest forms of mining in the world.
- Source: NEI Magazine
- Date: Tuesday, 10 June 2014
- Original article: neimagazine.com/news/newsuranium-mining-today-far-cry-from-bad-old-days---report-4289314